Abstract

The Triple Negative “Basal-like” breast cancer (TNBL) tumours have a high proliferative capacity and develop a resistance phenotype associated with metastases. However, the management of TNBL carcinomas is still not standardized. Among the promising trails, gold nanoparticles could be a relevant tool for the development of a targeted treatment for this breast cancer subtype in monotherapy, associated and/or conjugated with other drugs. In this work, we report the cytotoxicity impact of gold nanoparticles wrapped in Poly-Ethylene Glycol (PEG) on the TNBL HCC-1937 breast cancer cell line. PEG-coated gold nanoparticles (PEG-Au NPs) were synthesized by a two-step method using a reduction process followed by a post-functionalization called PEGylation. PEG-Au NPs were characterized using transmission electron microscopy and X-ray diffraction. The gold content of the samples was determined using atomic absorption spectrometer. The cytotoxicity tests were performed using Sulforhodamine B survival test and resazurin viability test. PEG-Au NPs impact analysis on HCC1937 TNBL cell line showed a clear toxic action of type dose dependent and at long term. These PEGylated gold nanoparticles present a promising tool for the development of tumor-specific radiosensitizing vectors, with or without the association of other treatment strategies.

Highlights

  • Gold nanoparticles (GNPs) are promising candidates in the field of medicine for the treatment of illnesses such as Alzheimer’s [1], vascular [2], skin [3], sclerosis [4] and cancer [5]

  • We report the cytotoxicity impact of gold nanoparticles wrapped in Poly-Ethylene Glycol (PEG) on the Triple Negative “Basal-like” breast cancer (TNBL) HCC-1937 breast cancer cell line

  • These works were focused on the cytotoxicity impact of gold nanoparticles wrapped in Poly-Ethylene Glycol (PEG), on the TNBL HCC-1937 breast cancer cell line

Read more

Summary

Introduction

Gold nanoparticles (GNPs) are promising candidates in the field of medicine for the treatment of illnesses such as Alzheimer’s [1], vascular [2], skin [3], sclerosis [4] and cancer [5]. The use of gold nanoparticles to try to cure cancer is a very active field of research With this nanomedicine strategy, gold nanoparticles are defined to target tumorous cells and minimize side effects [26] [27], to enhance conventional therapies [28] [29] or to develop new diagnostic and therapeutic devices [30] [31]. The management of TNBL carcinomas is still not standardized Among these promising trails, gold nanoparticles could be a relevant tool for the development of a targeted treatment for this breast cancer subtype in monotherapy, associated and/or conjugated with other drugs [40]. These works were focused on the cytotoxicity impact of gold nanoparticles wrapped in Poly-Ethylene Glycol (PEG), on the TNBL HCC-1937 breast cancer cell line

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call